GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Inflow
Outflow
Net flow
Funds Holding
2,998
Funds Holding Change
+14
Funds Holding Growth
+0.5%
Value
$552B
Holding in Top 10
487
Top 10 Change
+30
Top 10 Growth
+7%
Value Growth
+8%
New
127
Increased
1,286
Reduced
1,383
Closed
78
Capital Inflow
$25.6B
Capital Outflow
$17.1B
Net Capital Flow
+$8.47B
Capital Flow Change
+$15.8B
Calls
$5.04B
Puts
$6.59B
Net Calls
-$1.55B
Put/Call Ratio
1.31